Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02656017 · ClinicalTrials.gov registry record · Phase 2

Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease

A Phase 2 study of Polycystic Kidney, Autosomal Dominant, sponsored by Kyongtae Ty Bae, M.D., Ph.D..

Completed
Registry status
Phase 2
Development phase
97
Enrollment target
2
Study locations

NCT02656017 is a Phase 2 study of Polycystic Kidney, Autosomal Dominant that has completed, run by Kyongtae Ty Bae, M.D., Ph.D.. The registered enrollment target is 97 participants, above the 53-participant average among 4 other Polycystic Kidney, Autosomal Dominant trials with a reported enrollment target (83% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02656017, a Phase 2 study of Polycystic Kidney, Autosomal Dominant, has completed, sponsored by Kyongtae Ty Bae, M.D., Ph.D..

COMPLETED
Registry status
Phase 2
Development phase
97 participants
Enrollment target
2
Study locations

Study Summary

This study will test to see if metformin is safe and if it is tolerated compared to placebo in adult Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients with beginning stages of chronic kidney disease. We will also measure its effect on progression of kidney disease as reflected in the kidney size and the kidney function, along with its effect on kidney pain and quality of life.

Conditions Studied

Polycystic Kidney, Autosomal Dominant

Interventions

  • OTHER Placebo
  • DRUG Metformin

Study Locations (2)

Maryland

  • University of Maryland Medical Center - Baltimore

Massachusetts

  • Tufts Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2016-06-27
Est. Completion 2020-12-07
Phase Phase 2

Sponsor

Kyongtae Ty Bae, M.D., Ph.D.

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02656017

The ClinicalTrials.gov registry entry for NCT02656017 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 53-participant average among 4 other Polycystic Kidney, Autosomal Dominant trials with a reported enrollment target (83% higher). The listed sponsor is Kyongtae Ty Bae, M.D., Ph.D., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Polycystic Kidney, Autosomal Dominant appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02656017 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02656017 about?

NCT02656017 is a clinical study titled "Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease". This study will test to see if metformin is safe and if it is tolerated compared to placebo in adult Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients with beginning stages of chronic kidney disease. We will also measure its effect on progression of kidney disease as reflected in the kid...

What is the current status of trial NCT02656017?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 97 participants. The study started on 2016-06-27. Estimated completion is 2020-12-07.

What conditions does trial NCT02656017 study?

This clinical trial studies the following conditions: Polycystic Kidney, Autosomal Dominant.

What interventions are being tested in trial NCT02656017?

The interventions under investigation include: Placebo (OTHER), Metformin (DRUG).

Who is sponsoring clinical trial NCT02656017?

This trial is sponsored by Kyongtae Ty Bae, M.D., Ph.D., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02656017 being conducted?

This trial has 2 study locations across Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Polycystic Kidney, Autosomal Dominant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Polycystic Kidney, Autosomal Dominant

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.